Datametrex Conducts Over 23,700 COVID-19 Tests In Q4 Across Film Industry, Generating $4.0 Million In Revenue

Datametrex AI (TSXV: DM) this morning released data related to portions of its fourth quarter financial results, revealing that the company managed to conduct over 23,700 COVID-19 tests in the fourth quarter of 2020. Collectively, the tests reflect roughly $4.0 million in top-line revenue for the fourth quarter, while representing only one segment of the firms operations, with revenues being generated just from the film industry in Montreal, Vancouver and Toronto.

Datametrex AI's Logo

The figure is significant for the company, given that the third quarter saw COVID-19 test kits generate revenues of $2.3 million for the company, while the quarter across all segments saw revenues of $4.9 million. In fact, for the nine month period ended September 30, 2020, the company realized revenues of $3.7 million from that of COVID-19 test kits – making the latest quarterly performance an exceptional increase in test kit sales.

The company has indicated that it has continued to increase its capacity when it comes to COVID-19 test kits, with testing numbers said to be significantly improving from January 2021. Further, services will continue to expand for additional film and production companies, with production teams continuing to operate despite recent COVID-19 lockdowns.

“Our strong revenue growth reflects our focus on our experience within the film industry as well as our ability to roll out new shows seamlessly. With our pre-screening and screening tools, the film industry can continue to start new productions that provide much-needed content to the ever-expanding streaming services worldwide.”

Marshall Gunter, CEO of Datametrex

Datametrex AI last traded at $0.20 on the TSX Venture.


FULL DISCLOSURE: DataMetrex AI Limited is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover DataMetrex AI Limited on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Why $50 Silver, $4000 Gold Might Be Closer Than Anyone Thinks | Bradley Langille – GoGold Resources

Why Silver’s True Price Could Be Much Higher | Joaquín Marias – Argenta Silver

Gold Enters A ‘Stronger For Longer’ Phase | Richard Young – i-80 Gold

Recommended

Discovery Silver in Advanced Talks to Acquire Barrick’s Last Canadian Gold Mine

Emerita Reports Aznalcollar Public Tender Trial Hearings Have Concluded, Verdict Expected This Fall

Related News

Datametrex Launches Nexalogy SMART AI-Based Technology

Datametrex AI Limited (TSXV: DM) subsidiary Nexalogy has launched its Social Media Automated Reporting Technologies...

Wednesday, December 9, 2020, 03:26:00 PM

German Spy Agency Believed COVID-19 Likely Leaked from Chinese Lab, Media Reports

Germany’s foreign intelligence service concluded with 80-90% confidence that the coronavirus pandemic likely originated from...

Friday, March 14, 2025, 03:54:00 PM

Datametrex: COVID-19 Testing Continues To Thrive Despite Vaccines – The Daily Dive

For the final episode of the trading week, we see the return of Datametrex AI...

Friday, June 4, 2021, 01:30:00 PM

Revive Submits for IRB Approval; Expects to Enroll Patients in September

This morning Revive Therapeutics (CSE: RVV, USA: RVVTF) announced they have submitted a clinical trial...

Wednesday, August 26, 2020, 10:07:43 AM

Sona Nanotech Approved For Clinical Trials of Saliva-Based COVID-19 Rapid Test

Sona Nanotech (CSE: SONA) has been approved to begin clinical trials. The company this morning...

Tuesday, April 13, 2021, 08:21:40 AM